*sponsored by Sica Media
Good morning, 360!
Don’t forget to join us today for LIVE trading in the Market Master’s Room. Be the best prepared trader on the Street!
FOCUS LIST🔎
TUSK – Up over 34% in the pre-market after settlement agreement with PREPA for $188.4 million
FEIM – Up over 30% in pre after beating earnings estimates, announcing special cash dividend
SPOT – Up over 13% in pre after beating Q2 subscriber, profit targets
*sponsored by Sica Media
Go to your favorite platform and pull up Actinium Pharmaceuticals, Inc. (ATNM) right now, and I’ll show you what I see.
In the price chart below, you’ll see the year-to-date action for ATNM.
First of all, note the trend. It is clearly under accumulation and has been building a series of higher lows all year long (that’s the simple definition of an uptrend!)
That is extremely bullish, if you ask me.
ATNM is also up over 40% so far this year, which is nearly TRIPLE the return you have seen from the SPY.
Right now, the stock is at what I think is a key support level.
You never know what will happen in the future, but looking at how sharp ATNM’s rebounds have been this year, I think it really deserves your attention right now.
For my full thoughts on ATNM, see this page.
*Sponsored content/paid advertisement. This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results.
HOTLIST🔥
TUSK – Up over 34% in the pre-market after settlement agreement with PREPA for $188.4 million
Mammoth Energy Services, Inc. (TUSK) operates as an energy services company in the United States and internationally. The company operates in four segments: Well Completion Services, Infrastructure Services, Natural Sand Proppant Services, and Drilling Services.
In the after-hours yesterday, Cobra Acquisitions LLC (“Cobra”), a wholly owned subsidiary of Mammoth Energy Services, Inc., (TUSK) announced that it has entered into a release and settlement agreement with the Puerto Rico Electric Power Authority (“PREPA”) and the Financial Oversight and Management Board for Puerto Rico, to settle all outstanding matters between Cobra and PREPA.
Arty Straehla, Chief Executive Officer, commented,
“We are pleased to have reached this resolution with PREPA and look forward to receiving the money for work we concluded over five years ago. We plan to use a portion of the $188.4 million in settlement proceeds to pay off our term credit facility, which had a balance of approximately $49.3 million as of June 30, 2024. The remaining amount of approximately $139.1 million will be cash on our balance sheet to be used to invest back into our business and for general corporate purposes.”
The stock traded up over 34% in the pre-market in reaction to the news.
The $4.80 area acted as resistance in the after-hours and pre-market.
Above it, targets to the upside are $5.18, and then the after-hours high at $5.54. Beyond that, $5.75, $6, $6.50, $7 and $7.27 come into play.
Below $4.80, targets to the downside are $4.60, $4.40, $4.25, $4, $3.75 and then a gap fill at $3.50.
FEIM – Up over 30% in pre after beating earnings estimates, announcing special cash dividend
Frequency Electronics, Inc. (FEIM) together with its subsidiaries, engages in designing, development, and manufacturing of precision time and frequency control products and components for microwave integrated circuit applications.
In the after-hours yesterday the company reported Q4 and full year 2024 financial results.
Revenues for the three and twelve-month periods of fiscal year 2024, ended April 30, 2024, of approximately $15.6 million and $55.3 million, respectively, compared to revenues of $13.0 million and $40.8 million, respectively, for the same periods of fiscal year 2023, ended April 30, 2023.
Net income for the three months ended April 30, 2024 was $2.6 million or $0.28 per diluted share and net income for the twelve months ended April 30, 2024 was $5.6 million or $0.59 per diluted share, compared to net income of $0.2 million or $0.03 per diluted share for the three months ended April 30, 2023 and net loss of $5.5 million or ($0.59) per diluted share for the twelve months ended April 30, 2023.
FEIM also announced that it will be paying a special cash dividend of $1.00 per share of common stock on August 29, 2024, to stockholders of record as of the close of business on August 8, 2024.
The stock traded up over 12% in the pre-market in reaction to the news.
The first target for bulls is the pre-market high at $14.35.
Beyond that, targets to the upside are $15, $16, $17, $19 and $20.
Below $14.35, targets to the downside are $14, $13.30, $13, $12.60, $12, $11 and then a gap fill at $10.10.
New to Options Trading?
How does trading ONE Stock, Every Day sound?
Dip your toe in with JW and his crew in Market Navigator!
Special Trial only $79 now available.
(share this link with a friend if you’re already a pro!)
SPOT – Up over 13% in pre after beating Q2 subscriber, profit targets
Spotify Technology S.A. (SPOT) together with its subsidiaries, provides audio streaming subscription services worldwide.
In the pre-market this morning, the company announced Q2 earnings and subscriber numbers.
SPOT reported operating income of 266 million euros ($289 million), compared with a loss of 247 million euros in the prior-year period. This was above company guidance of 250 million euros, driven by “lower personnel and related costs and lower marketing spend.”
It also guided to a strong Q3 operating income of 405 million euros ($440 million), well ahead of Wall Street consensus expectations of 298.1 million euros.
The streaming service reported net income of 274 million euros ($298 million), or earnings of 1.33 euros per share. That was well ahead of analyst expectations of earnings of 1.04 euros per share. It also compares with the year-earlier period loss of 302 million euros, or a loss of 1.55 euros a share.
Premium subscribers came in above company expectations of 245 million to hit 246 — a 12% year-over-year jump. Spotify expects the subscriber count to increase to 251 million in the third quarter.
The average revenue per user, or ARPU, for Premium subscriptions increased 8% year over year to 4.62 euros.
SPOT stock traded up over 13% in the pre-market in reaction to the news.
The first target for bulls is $339.10 and then the pre-market high at $341.
Beyond that, $350 and $360 come into play.
Below $339.10, targets to the downside are $331.40, $322, $310 and then $300.
MARKET NEWS 📰
👊 Make sure you are getting my mobile text alerts – text “RAGE” to 1-(888) 404-5747 to get all of my latest HOT STOCK ideas delivered right to your phone (make sure you put the “1” at the front!). Don’t miss out!
Questions or concerns about our products? Email Support@360wallstreet.io © Copyright 2022, RagingBull
*Just so you know, what you’re reading is curated content for which we have received a monetary fee (detailed below) to create and distribute. Let’s be clear that investing can be quite the roller coaster as stock prices can have wild swings up and down, so consider those crucial risks before you ever consider trading anything we discuss. Make sure you check out our full disclosure down below for the details on how we were paid, the risks, and why these results aren’t what you’d call “typical.”
Just a quick heads up about this ad you’re reading—as we’ve said, even though we like the company referenced above, and all the facts we discussed above are true to the best of our knowledge, we are running a business here. To distribute this information and help offset the costs of maintaining our large digital audience, in advance of writing the content above, we received thirty thousand dollars (cash) from Sica Media for advertising Actinium Pharmaceuticals, Inc for a one day marketing program on July 23, 2024. We previously received seventeen thousand five hundred dollars from Sica Media who was compensated by a third party not affiliated with the Company for advertising Actinium Pharmaceuticals, Inc from a period beginning on for a one day marketing program on March 18, 2024. These amounts were paid by someone else not connected to Actinium Pharmaceuticals, Inc. It might be obvious, but whoever paid for this might own shares and is likely looking to sell some or all of them at any time after we send out this information, which might affect the stock price. We may also buy or sell shares in the company at some point in the future, although neither RagingBull nor its owners own any shares of the company at this time. Also, keep in mind that due to the sheer size of our audience, if even a small percentage of people decide they want to buy this stock, it could potentially boost interest enough to hike up those share prices and cause a temporary spike, and the opposite is possible as our program ends, though that is not always the case.
Now, diving right into Actinium Pharmaceuticals, Inc might sound exciting. But remember, it’s like venturing into the wilderness—be aware that there’s exceptional risk involved in trading. This isn’t small potatoes we’re talking about; you could lose every dime you put in, so always carefully think about what you’re doing. That’s why they call this trading, after all. We’re shining a light on the good stuff about the company here, but it’s on you to do your homework, make your own calls, and determine a plan for your own trading, hopefully with the help of your professional 1nvestment advis0r.
Oh, that brings us to another crucial point—we’re not here to tell you (or even recommend) what you should do with your hard-earned money. We’re simply sharing our non-expert thoughts by highlighting some companies we like that could use some help telling their story to more people. We’re obviously biased in our writing. We’re not here to dig into anything that may be negative about the company; this is advertising, after all! Also, keep in mind that if we make some predictions about the future, these are technically known as “forward-L00king statements” under the securities acts, so take those with a grain of salt. As with all forecasts, they’re not set in stone, often wrong, and we certainly can’t know where the Company’s earnings, business, or share price will be tomorrow or a year from now.
Everything you read from us is all for your education, information, and possible entertainment. While we believe the info is reliable and accurate, we can’t wear a cape and guarantee it. Before you jump into anything, make sure to talk it over with a pro—someone you trust who’s licensed to give you real advice. To be clear,
Neither Raging Bull nor its owners, employees, or independent contractors are registered as a secur1ties br0ker-dealer, br0ker, 1nvestment advis0r (IA), or IA rep’s with the SEC, any state securities regulat0ry authority, or any self-regulat0ry organization.
So, that’s the scoop! If you’re intrigued and want to learn more about the companies we talk about, hit up the SEC’s website to dig into their filings and see the full picture.
